When: Weekly close below $349.61 (200 SMA structural break)

Then: Full exit of position

HOLD - Maintain current plan as written; resist aggressive pressure to go full underweight or short

• Traders plan already incorporates bear case: 30-50% trim, 50-70% underweight, no new longs at 372, no net short, stop at 405
• 200 SMA at 350 is meaningful liquidity level, not just lagging indicator - represents annual cost basis with historical reflexive bounces
• Aggressive risk-reward flawed: 33 point risk (372 to 405) against 22 point target (372 to 350) creates worse than 1.5 to 1 ratio
• October 13 catalyst asymmetric read wrong: Q1 EPS 6.90 and Q2 EPS 6.04 show recovery; probability more like 60-65% in-line or better vs 35-40% miss
• Institutional accumulation in progress: turnaround pieces, dividend yield framing, AI positioning - retail absence is normal for large-cap healthcare, not bearish signal
• Defensive characteristics (0.62 beta, 7.3% FCF yield, 2.46% dividend) define drawdown floor rather than stop falling knife
• P/E at 16.5x is low end of 18-25x historical range - re-rating potential of 3-5 turns if sentiment improves
• Aggressive is selling optionality at wrong price: options market implies 5-7% move, not the 19% downside being bet
• Plan preserves upside participation (clean print to 400) while reducing risk through trim rather than one-way directional bet
• Full underweight creates gap risk: clean print could gap 5-8% overnight leaving whipsaw damage and buy-high situation

→ vs aggressive: Risk-reward on short side is worse than 1.5 to 1 with 33 point risk to 405 stop vs 22 point target to 200 SMA, and aggressive hasn't acknowledged gap risk on pre-earnings binary event

→ vs aggressive: Sentiment read is flawed - zero Reddit posts reflects retail's absence from large-cap defensive healthcare, not narrative cycle end; institutional turnaround pieces indicate accumulation, not distribution

→ vs aggressive: Asymmetric framing assumes 50-50 miss probability when fundamentals show 60-65% probability of in-line or better given Q1-Q2 recovery and telegraphed cost issues

→ vs aggressive: Value trap framing ignores that 16.5x is at low end of historical 18-25x range, meaning aggressive gives up multiple re-rating upside unnecessarily

→ vs aggressive: Over-reading compressed Bollinger bands as bearish when neutral consolidation is equally valid interpretation for 30% off highs name at 16.5x with 7% FCF yield

Trim 30-50% faster than the 2-4 week window, targeting underweight; hedge via options (collar or protective puts); no net short; reassess dynamically post-Oct 13 earnings

• UNH trades at 16.5x forward earnings, at the low end of its historical 18-25x range—not a value trap but potentially underpriced recovery
• Forward P/E implies earnings could hit $22.61, above even 2023's record, making current price potentially cheap if recovery materializes
• Commercial MLR is above the 11% trend in UNH's largest segment
• Medicaid margins expected to stay pressured through 2026
• Institutional press writing turnaround pieces signals accumulation, not distribution
• Trim 30-50% faster than 2-4 week window to reduce pre-earnings volatility exposure
• Use options hedges—collars (selling calls to finance puts) or protective puts—to cap downside around Oct 13 catalyst
• Post-earnings: add back if beat and trend reversal confirmed (RSI reclaiming 50, price above 50 SMA); maintain underweight if miss
• No net short warranted—franchise quality and balance sheet support the underweight stance but not a one-way bet

→ vs aggressive: Framing UNH as a 'value trap' overreaches—16.5x forward P/E at low end of 18-25x historical range suggests market is pricing skepticism that's overdone given Q1/Q2 2026 EPS rebounds to $6.90 and $6.04

→ vs aggressive: Zero Reddit posts indicates retail simply doesn't trade this $335B mega-cap defensive name—not distribution pattern-matching a GameStop-style exit setup

→ vs conservative: Too comfortable assuming cost trend issue (commercial MLR above 11% trend in largest segment, Medicaid margins pressured through 2026) is fully priced or will normalize—two quarters of recovery don't guarantee a third

→ vs conservative: '60-65% chance of in-line or better' lacks hard data foundation and underestimates the binary nature of the Oct 13 catalyst

→ vs conservative: Over-reliance on 200 SMA at $350 as a hard floor is a lagging indicator that won't hold if fundamentals crack—UNH already down 20% from highs